109 related articles for article (PubMed ID: 36941341)
1. Prolactin Rescues Immature B-Cells from Apoptosis Induced by B-Cell Receptor Cross-Linking.
Flores-Fernández R; Blanco-Favela F; Fuentes-Pananá EM; Chávez-Sánchez L; Gorocica-Rosete P; Pizaña-Venegas A; Chávez-Rueda AK
J Immunol Res; 2016; 2016():3219017. PubMed ID: 27314053
[TBL] [Abstract][Full Text] [Related]
2. Targeted engagement of β-catenin-Ikaros complexes in refractory B-cell malignancies.
Cosgun KN; Jumaa H; Robinson ME; Kistner KM; Xu L; Xiao G; Chan LN; Lee J; Kume K; Leveille E; Fonseca-Arce D; Khanduja D; Ng HL; Feldhahn N; Song J; Chan WC; Chen J; Taketo MM; Kothari S; Davids MS; Schjerven H; Jellusova J; Müschen M
bioRxiv; 2023 Mar; ():. PubMed ID: 36993619
[TBL] [Abstract][Full Text] [Related]
3. Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signaling.
Lee J; Robinson ME; Sun R; Kume K; Ma N; Cosgun KN; Chan LN; Leveille E; Geng H; Vykunta VS; Shy BR; Marson A; Katz S; Chen J; Paietta E; Meffre E; Vaidehi N; Müschen M
bioRxiv; 2023 Mar; ():. PubMed ID: 36993276
[TBL] [Abstract][Full Text] [Related]
4. The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies.
Filipek-Gorzała J; Kwiecińska P; Szade A; Szade K
Front Oncol; 2024; 14():1308709. PubMed ID: 38440231
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer and Prolactin - New Mechanisms and Models.
Clevenger CV; Rui H
Endocrinology; 2022 Oct; 163(10):. PubMed ID: 35922139
[TBL] [Abstract][Full Text] [Related]
6. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms.
Taghi Khani A; Kumar A; Sanchez Ortiz A; Radecki KC; Aramburo S; Lee SJ; Hu Z; Damirchi B; Lorenson MY; Wu X; Gu Z; Stohl W; Sanz I; Meffre E; Müschen M; Forman SJ; Koff JL; Walker AM; Swaminathan S
Commun Biol; 2023 Mar; 6(1):295. PubMed ID: 36941341
[TBL] [Abstract][Full Text] [Related]
7. Expression of autocrine prolactin and the short isoform of prolactin receptor are associated with inflammatory response and apoptosis in monocytes stimulated with Mycobacterium bovis proteins.
López-Rincón G; Mancilla R; Pereira-Suárez AL; Martínez-Neri PA; Ochoa-Zarzosa A; Muñoz-Valle JF; Estrada-Chávez C
Exp Mol Pathol; 2015 Jun; 98(3):517-26. PubMed ID: 25797370
[TBL] [Abstract][Full Text] [Related]
8. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the intermediate isoform of the human prolactin receptor.
Kline JB; Roehrs H; Clevenger CV
J Biol Chem; 1999 Dec; 274(50):35461-8. PubMed ID: 10585417
[TBL] [Abstract][Full Text] [Related]
10. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
Ogueta S; Muñoz J; Obregon E; Delgado-Baeza E; García-Ruiz JP
Mol Cell Endocrinol; 2002 Apr; 190(1-2):51-63. PubMed ID: 11997178
[TBL] [Abstract][Full Text] [Related]
11. Prolactin promotes proliferation of germinal center B cells, formation of plasma cells, and elevated levels of IgG3 anti-dsDNA autoantibodies.
Carreón-Talavera R; Santana-Sánchez P; Fuentes-Pananá EM; Legorreta-Haquet MV; Chávez-Sánchez L; Gorocica-Rosete PS; Chávez-Rueda AK
Front Immunol; 2022; 13():1017115. PubMed ID: 36389691
[TBL] [Abstract][Full Text] [Related]
12. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
Kavarthapu R; Dufau ML
Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
[TBL] [Abstract][Full Text] [Related]
13. Splicing dysregulation in human hematologic malignancies: beyond splicing mutations.
De Kesel J; Fijalkowski I; Taylor J; Ntziachristos P
Trends Immunol; 2022 Aug; 43(8):674-686. PubMed ID: 35850914
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
